LncRNA LBX2-AS1 promotes colorectal cancer progression and 5-fluorouracil resistance.
- DOI
- 10.1186/s12935-021-02209-y
- Published
- 2021 Sep 17
- Container
- Cancer cell international
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
serious concern Score 18/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12935-021-02209-y,
title = {LncRNA LBX2-AS1 promotes colorectal cancer progression and 5-fluorouracil resistance.},
author = {Ma YN and Hong YG and Yu GY and Jiang SY and Zhao BL and Guo A and Wang Y and Cui XM and Hao LQ and Zheng H},
year = {2021},
journal = {Cancer cell international},
doi = {10.1186/s12935-021-02209-y},
url = {https://doi.org/10.1186/s12935-021-02209-y}
}RIS
TY - JOUR TI - LncRNA LBX2-AS1 promotes colorectal cancer progression and 5-fluorouracil resistance. AU - Ma YN AU - Hong YG AU - Yu GY AU - Jiang SY AU - Zhao BL AU - Guo A AU - Wang Y AU - Cui XM AU - Hao LQ AU - Zheng H PY - 2021 JO - Cancer cell international DO - 10.1186/s12935-021-02209-y UR - https://doi.org/10.1186/s12935-021-02209-y ER -
APA
YN, M., YG, H., GY, Y., SY, J., BL, Z., A, G., Y, W., XM, C., LQ, H., & H, Z. (2021). LncRNA LBX2-AS1 promotes colorectal cancer progression and 5-fluorouracil resistance.. Cancer cell international. https://doi.org/10.1186/s12935-021-02209-y
Source records
- pubmed · retrieved 2026-09-26T10:37:59.457Z
- europe-pmc · retrieved 2026-09-26T10:37:59.469Z
- doaj · retrieved 2026-09-26T10:37:59.459Z